 Lycopene has been shown to reduce the risk of developing nephrotoxicity caused by cisplatin-based chemotherapy in patients with cancer. This study found that Lycopene supplementation could help to reduce the severity of nephrotoxicity symptoms such as elevated blood urea nitrogen levels and reduced glomerular filtration rates. Additionally, Lycopene may also help to delay the progression of these symptoms over time. This article was authored by Leila Mamudnia, Kavan Mohammadi, and Rohala Masumi.